Literature DB >> 7527449

IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages.

R E Akridge1, L K Oyafuso, S G Reed.   

Abstract

IL-10 has been shown to be capable of down-regulating several aspects of macrophage function. This study was undertaken to define the association between IL-10 and HIV-1 infection in human macrophages. Infection of macrophages with a monocytotropic strain of the human immunodeficiency virus, HIV-BaL, resulted in expression of IL-10 mRNA within 3 to 12 h after infection, as determined by the reverse transcriptase PCR. Biologically active IL-10 was detected in supernatants from HIV-1-infected macrophages as early as 12 h post-infection. The addition of human rIL-10 to HIV-1-infected macrophage cultures resulted in a significant decrease in the viral replication. In addition, exogenous IL-10 blocked the ability of TNF-alpha to elevate viral replication. To determine whether IL-10 was associated with in vivo infection, lymph nodes from AIDS patients were examined for the presence of IL-10 mRNA by using PCR. IL-10 mRNA was evident in all lymph node tissue examined, but was absent in normal lymph node biopsies. These in vitro and in vivo findings demonstrate a strong and heterogeneous association between HIV-1 infection and IL-10.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527449

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

1.  IL-10 in HIV infection: increasing serum IL-10 levels with disease progression--down-regulatory effect of potent anti-retroviral therapy.

Authors:  E Stylianou; P Aukrust; D Kvale; F Müller; S S Frøland
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

2.  Interleukin-12 p40 mRNA expression in bovine leukemia virus-infected animals: increase in alymphocytosis but decrease in persistent lymphocytosis.

Authors:  D Pyeon; G A Splitter
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

Review 3.  DNA gene vaccination for HIV.

Authors:  J J Kim; D B Weiner
Journal:  Springer Semin Immunopathol       Date:  1997

4.  Nef protein of human immunodeficiency virus and lipopolysaccharide induce expression of CD14 on human monocytes through differential utilization of interleukin-10.

Authors:  David Creery; Jonathan B Angel; Susan Aucoin; William Weiss; William D Cameron; Francisco Diaz-Mitoma; Ashok Kumar
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

5.  In vitro suppression of human immunodeficiency virus type 1 replication by measles virus.

Authors:  Mayra García; Xiao-Fang Yu; Diane E Griffin; William J Moss
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  HIV-1 does not alter in vitro and in vivo IL-10 production by human monocytes and macrophages.

Authors:  A Bergamini; F Bolacchi; E Faggioli; R Placido; S Vendetti; L Cappannoli; L Ventura; G Cerasari; I Uccella; M Andreoni; G Rocchi
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

7.  Extended IL10 haplotypes and their association with HIV progression to AIDS.

Authors:  T K Oleksyk; S Shrestha; A L Truelove; J J Goedert; S M Donfield; J Phair; S Mehta; S J O'Brien; M W Smith
Journal:  Genes Immun       Date:  2009-03-19       Impact factor: 2.676

Review 8.  The macrophage in HIV-1 infection: from activation to deactivation?

Authors:  Georges Herbein; Audrey Varin
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

9.  EIAV S2 enhances pro-inflammatory cytokine and chemokine response in infected macrophages.

Authors:  Lina Covaleda; Frederick J Fuller; Susan L Payne
Journal:  Virology       Date:  2009-11-28       Impact factor: 3.616

10.  Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function.

Authors:  M Nedim Ince; Brooke Harnisch; Zhan Xu; Sang-Kyung Lee; Christoph Lange; Lorenzo Moretta; Michael Lederman; Judy Lieberman
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.